Expression of mPOU protein in the human pituitary adenomas

Yoshio Sakagami1, Yasuhiko Okimura, Takeshi Kondoh

  • 1Division of Neurosurgery, Department of Organs Therapeutics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.

Abstract

Insights

The mouse POU (mPOU) protein is expressed in pituitary adenomas, particularly in growth hormone (GH)-producing and prolactin (PRL)-producing tumors. This suggests mPOU may play a role in regulating GH and PRL gene expression alongside Pit-1.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • The POU protein family, specifically mPOU (class VI), is found in the pituitary gland and other tissues.
  • Previous research indicated mPOU's role in promoting growth hormone (GH) and prolactin (PRL) gene transcription by binding to Pit-1 DNA elements.
  • Pit-1 is a known transcription factor critical for GH and PRL gene expression.

Purpose of the Study:

  • To investigate the expression patterns of mPOU protein within pituitary adenomas.
  • To determine if mPOU expression correlates with specific types of pituitary adenomas, particularly those producing GH and PRL.

Main Methods:

  • Immunohistochemical analysis using the ABC method was performed on tissue sections from 17 pituitary adenoma patients.
  • Tumor samples included prolactinomas (PRL), somatotropinomas (GH), gonadotropinomas (FSH), and non-functioning adenomas.
  • Tumor excision was conducted via a transsphenoidal approach.

Main Results:

  • mPOU protein was specifically detected in GH-producing adenomas.
  • mPOU protein was also specifically detected in PRL-producing adenomas.
  • Expression of mPOU protein was predominantly observed in the nuclei of tumor cells.

Conclusions:

  • The findings indicate that mPOU protein is expressed in GH-producing and PRL-producing pituitary adenomas.
  • While Pit-1 is established as a key regulator, mPOU may also contribute to the regulation of GH and PRL gene expression in the pituitary.
  • mPOU's specific expression in these adenoma types suggests a potential role in pituitary tumorigenesis or function.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hormones of the Pituitary Gland01:27

Hormones of the Pituitary Gland

The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...